Compare CYTK & AGNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CYTK | AGNC |
|---|---|---|
| Founded | 1997 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.7B | 12.6B |
| IPO Year | 2004 | 2008 |
| Metric | CYTK | AGNC |
|---|---|---|
| Price | $60.83 | $8.68 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 22 | 14 |
| Target Price | ★ $109.90 | $11.06 |
| AVG Volume (30 Days) | 1.8M | ★ 29.5M |
| Earning Date | 11-04-2026 | 10-19-2026 |
| Dividend Yield | N/A | ★ 16.55% |
| EPS Growth | N/A | ★ 58.06 |
| EPS | N/A | ★ 0.37 |
| Revenue | ★ $13,368,000.00 | N/A |
| Revenue This Year | $70.12 | N/A |
| Revenue Next Year | $183.63 | $22.94 |
| P/E Ratio | ★ N/A | $23.47 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $54.30 | $8.59 |
| 52 Week High | $88.31 | $12.19 |
| Indicator | CYTK | AGNC |
|---|---|---|
| Relative Strength Index (RSI) | 24.31 | 16.57 |
| Support Level | $59.05 | N/A |
| Resistance Level | $67.04 | $11.54 |
| Average True Range (ATR) | 2.06 | 0.18 |
| MACD | -0.37 | -0.11 |
| Stochastic Oscillator | 3.95 | 6.56 |
Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary disease. The company's product, named as MYQORZO, is an allosteric and reversible inhibitor of cardiac myosin motor activity. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.
AGNC Investment Corp is a real estate investment trust that invests in agency residential mortgage-backed securities. The firm's asset portfolio is comprised of residential mortgage pass-through securities and collateralized mortgage obligations for which the principal and interest payments are guaranteed by a U.S. Government-sponsored enterprise, such as the Federal National Mortgage Association and the Federal Home Loan Mortgage Corporation, or by a U.S. Government agency, such as the Government National Mortgage Association. It also invests in other types of mortgage and mortgage-related residential and commercial mortgage-backed securities or other investments in or related to, the housing, mortgage, or real estate markets.